
Duchenne Muscular Dystrophy (DMD): What It Is & Symptoms
Duchenne muscular dystrophy (DMD) is a condition that causes skeletal and heart muscle weakness that quickly gets worse with time. Symptoms usually begin by age 6.
Duchenne muscular dystrophy - Wikipedia
Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. [3][7][8] The onset of muscle weakness typically begins around age four, with rapid …
Diseases - Duchenne Muscular Dystrophy (DMD)
Duchenne muscular dystrophy (DMD) is a progressive, genetic (X-linked recessive) neuromuscular disorder caused by mutations to the DMD gene, resulting in the dysfunction or absence of the …
Duchenne Muscular Dystrophy - Johns Hopkins Medicine
Duchenne muscular dystrophy, or DMD, is associated with the most severe clinical symptoms of all the muscular dystrophies. It is caused by a genetic mutation on one of the mother’s X chromosomes, …
Duchenne Muscular Dystrophy: Symptoms, Diagnosis, and Treatment - WebMD
Nov 4, 2025 · Duchenne muscular dystrophy (DMD) is a rare muscle weakening disease that mostly affects boys. Learn about the causes, symptoms, treatment, and other parts of managing DMD.
Duchenne Muscular Dystrophy - StatPearls - NCBI Bookshelf
Jul 10, 2023 · Duchenne muscular dystrophy (DMD) is one of the most severe forms of inherited muscular dystrophies. It is the most common hereditary neuromuscular disease and does not exhibit …
Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is the most common type of muscular dystrophy. Symptoms usually develop before age 5 years and can affect many parts of the body, including the heart and …
What To Know About Duchenne Muscular Dystrophy (DMD) - Health
Feb 20, 2025 · Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscular weakness and mild intellectual disability.
3-drug cocktail boosts DMD gene therapy effectiveness in mice
5 days ago · A regimen of three immune-suppressing drugs may improve the effectiveness of gene therapy for people with DMD, research in mice suggests.
Deramiocel Slows DMD Progression in Phase 3 Trial - MPR
4 days ago · The Company plans to submit its response to the CRL, including the results from the HOPE-3 trial, to address the Agency's previous requests for additional data.